Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Saxenda (liraglutide 3 mg for weight loss) is being phased out by Novo Nordisk globally as the company reallocates manufacturing capacity toward newer GLP-1 medications
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
This makes it a better fit for high-performance serums and targeted treatments where you want the strongest possible effect with a lower amount of the substance
PMID: 16508911
As rates of obesity remain high in the hemophilia population, more individuals may be managing both diabetes and hemophilia
Frontiers in Pharmacology , 15
Why researchers are paying attention The reclassification reflects a broader shift: after several years of accumulated preclinical data and community advocacy, regulators are re-examining an earlier, broad-brush approach
US$ 28.12
US$ 25.26
US$ 26.96
US$ 23.14
US$ 29.02
US$ 29.76
